HK1050892A1 - Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1- (substituted) hydrazines. - Google Patents

Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1- (substituted) hydrazines.

Info

Publication number
HK1050892A1
HK1050892A1 HK03103134A HK03103134A HK1050892A1 HK 1050892 A1 HK1050892 A1 HK 1050892A1 HK 03103134 A HK03103134 A HK 03103134A HK 03103134 A HK03103134 A HK 03103134A HK 1050892 A1 HK1050892 A1 HK 1050892A1
Authority
HK
Hong Kong
Prior art keywords
methylsulfonyl
bis
aminocarbonyl
chloroethyl
hydrazines
Prior art date
Application number
HK03103134A
Other languages
English (en)
Inventor
Alan C Sartorelli
Krishnamurthy Shyam
Philip G Penketh
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of HK1050892A1 publication Critical patent/HK1050892A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/55—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03103134A 1995-07-05 2003-05-02 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1- (substituted) hydrazines. HK1050892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/497,931 US5637619A (en) 1995-07-05 1995-07-05 Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines

Publications (1)

Publication Number Publication Date
HK1050892A1 true HK1050892A1 (en) 2003-07-11

Family

ID=23978924

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103134A HK1050892A1 (en) 1995-07-05 2003-05-02 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1- (substituted) hydrazines.

Country Status (16)

Country Link
US (1) US5637619A (da)
EP (1) EP0841912B1 (da)
JP (1) JP3869007B2 (da)
KR (1) KR100372632B1 (da)
CN (2) CN1095828C (da)
AT (1) ATE224708T1 (da)
AU (1) AU713128B2 (da)
BR (1) BR9609620A (da)
CA (1) CA2226331C (da)
DE (1) DE69623969T2 (da)
DK (1) DK0841912T3 (da)
ES (1) ES2179204T3 (da)
HK (1) HK1050892A1 (da)
PT (1) PT841912E (da)
SI (1) SI0841912T1 (da)
WO (1) WO1997002029A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040338A (en) * 1997-11-03 2000-03-21 Yale University N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
KR100578425B1 (ko) * 1998-10-16 2007-01-11 씨제이 주식회사 캐테콜 히드라진 유도체, 이의 제조 방법 및 이를 함유한 약제학적 조성물
US6855695B2 (en) * 2003-06-13 2005-02-15 Vion Pharmaceuticals, Inc. Water-soluble SHPs as novel alkylating agents
EP1804816B1 (en) * 2004-03-26 2011-12-21 Vion Pharmaceuticals, Inc. Combination therapy comprising cloretazine(tm)
JP4814245B2 (ja) * 2004-09-21 2011-11-16 ヴァイオン ファーマシューティカルズ、インコーポレーテッド 低酸素選択性抗腫瘍剤としてのスルホニルヒドラジンのリン酸含有プロドラッグ
WO2016033105A1 (en) * 2014-08-29 2016-03-03 The Board Of Regents Of The University Of Texas System Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
KR102643986B1 (ko) 2017-09-29 2024-03-07 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 인덴계 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
KR102100142B1 (ko) 2017-12-21 2020-04-14 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 금속-리간드 착체, 이를 포함하는 에틸렌계 중합용 촉매 조성물 및 이를 이용한 에틸렌계 중합체의 제조방법
KR20210069578A (ko) 2019-12-03 2021-06-11 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 전이금속 화합물, 이를 포함하는 촉매 조성물 및 이를 이용하는 올레핀 중합체의 제조방법
KR20210086505A (ko) 2019-12-30 2021-07-08 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 전자 당김 그룹을 갖는 금속-리간드 착체, 이를 포함하는 에틸렌계 중합체 제조용 촉매 조성물 및 이를 이용한 에틸렌계 중합체의 제조방법
KR20220094138A (ko) 2020-12-28 2022-07-05 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 금속-리간드 착체, 이를 포함하는 에틸렌계 중합체 제조용 촉매 조성물 및 이를 이용한 에틸렌계 중합체의 제조방법
KR20230101716A (ko) 2021-12-29 2023-07-06 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 전이금속 화합물, 이를 포함하는 촉매 조성물 및 이를 이용하는 올레핀 중합체의 제조방법
KR20230101717A (ko) 2021-12-29 2023-07-06 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 금속-리간드 착체, 이를 포함하는 에틸렌계 중합체 제조용 촉매 조성물 및 이를 이용한 에틸렌계 중합체의 제조방법
KR20240049151A (ko) 2022-10-07 2024-04-16 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 전이금속 화합물, 이를 포함하는 촉매 조성물 및 이를 이용하는 올레핀 중합체의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175200A (en) * 1975-04-11 1979-11-20 Uniroyal, Inc. N,N-Disubstituted sulfonyl hydrazines
US4684747A (en) * 1984-12-20 1987-08-04 Yale University N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US4849563A (en) * 1986-01-21 1989-07-18 Yale University Novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity
US5214068A (en) * 1989-09-06 1993-05-25 Yale University Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents
US5101072A (en) * 1989-09-06 1992-03-31 Yale University Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents
US5256820A (en) * 1991-11-08 1993-10-26 Yale University 1-alkyl-2-acyl-1,2-disulfonylhydrazines

Also Published As

Publication number Publication date
BR9609620A (pt) 1999-12-21
ATE224708T1 (de) 2002-10-15
EP0841912A4 (en) 1998-10-14
ES2179204T3 (es) 2003-01-16
MX9800129A (es) 1998-03-31
SI0841912T1 (en) 2002-12-31
CN1176067C (zh) 2004-11-17
EP0841912A1 (en) 1998-05-20
AU1193497A (en) 1997-02-05
US5637619A (en) 1997-06-10
EP0841912B1 (en) 2002-09-25
JPH11508898A (ja) 1999-08-03
JP3869007B2 (ja) 2007-01-17
CA2226331C (en) 2009-05-26
DE69623969T2 (de) 2003-05-28
CA2226331A1 (en) 1997-01-23
WO1997002029A1 (en) 1997-01-23
CN1095828C (zh) 2002-12-11
PT841912E (pt) 2003-01-31
DE69623969D1 (en) 2002-10-31
AU713128B2 (en) 1999-11-25
KR19990028733A (ko) 1999-04-15
KR100372632B1 (ko) 2003-05-12
DK0841912T3 (da) 2002-11-11
CN1405152A (zh) 2003-03-26
CN1191482A (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
MY121548A (en) Compounds and methods for the treatment of cancer
HK1050892A1 (en) Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1- (substituted) hydrazines.
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
BR9814857A (pt) Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
AU1808488A (en) Compounds for the treatment of alzheimer&#39;s disease
FR2657259B1 (da)
PT815087E (pt) Derivados de fenilo trissubstituidos
TR200101693T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
GB9505082D0 (en) Medicament
ZA981558B (en) Inclusion complexes in aqueous solution
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
ES2072431T3 (es) D-acido aspartico beta-hidroxamato para el tratamiento de infecciones virales y de tumores.
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
GB9723824D0 (en) Cytostatic agents
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.
DE3373907D1 (en) N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor
MX9707811A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos, n-clorofeniltiocarbamatos y derivados de n-fosfonoglicina para inhibir el crecimiento de canceres y virus en mamiferos.
RU95100512A (ru) Мазь для лечения кожных заболеваний

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160701